Displaying 1-10 of 10 result(s).
| Board Name | Posts By TEXMEX | Post Created |
|---|---|---|
| ZRFY Zerify Inc | Is ZPAUL still trying to distance h  (1) | 10/30/2020 4:58:18 PM |
| ZRFY Zerify Inc | Been gone for a few months, waiting | 06/26/2020 11:06:47 AM |
| ZRFY Zerify Inc | Looks like a lot of longs walked th (4) | 03/23/2020 5:42:35 PM |
| ZRFY Zerify Inc | Emailed Mark Kay yesterday and rece (5) | 01/28/2020 11:16:16 AM |
| ZRFY Zerify Inc | Remember DSS ponied up 500,000 doll (2) | 11/08/2019 12:04:24 PM |
| ZRFY Zerify Inc | I had called Mcafee before and inqu | 09/14/2019 4:43:35 PM |
| ZRFY Zerify Inc | This may help a little, quote from (1) | 08/19/2019 6:52:45 PM |
| ZRFY Zerify Inc | I believe Monday will be the day. (2) | 08/18/2019 11:12:00 AM |
| ZRFY Zerify Inc | Does anybody remember how much DSS (1) | 08/10/2019 5:47:09 PM |
| ZRFY Zerify Inc | Well I just purchased Guarded ID ye | 06/12/2019 1:49:38 PM |
Recent Articles
- Understanding Key Economic Strategies from China's Leadership Meeting
- Financière de Tubize Announces Annual Dividend Distribution
- Celebrating Cinema at the 20th China Film Huabiao Awards
- Movado Group Faces SEC Scrutiny, Rosen Law Firm Steps In
- Experience the Thrill of Japan Open Poker Tour 2025
- A.I.S. Resources Completes Successful Private Placement Initiative
- Ready Capital Shareholder Legal Updates: Know Your Rights
- Investors Urged to Act: Lawsuits Filed Against e.l.f. Beauty
- Understanding Your Rights as a Bancorp Investor in Legal Matters
- Important Update for Viatris Investors: Legal Action Insights
- AppLovin Investors Reminded of Important Class Action Deadline
- Investors Have a Deadline to Join NET Power Class Action
- Fluence Energy Class Action Update: Important Deadline Approaches
- AppLovin Corporation Faces Shareholder Class Action Opportunities
- Formosa Pharmaceuticals Partners With Saval For New Eye Treatment
- Antengene Showcases Innovative Therapeutics at AACR Event
- 51Talk Online Education Group Releases Key Annual Report for 2024
- Skye Bioscience Unveils Stock Option Grant for New Employee
- Innovent Celebrates NMPA Approval of Limertinib for Lung Cancer Treatment
- Willow Biosciences Reveals Results from Recent Shareholder Meeting
- Investigation into Bitfarms Ltd: What Investors Should Know
- Investigation into HealthEquity, Inc. Sparks Investor Interest
- Creative Science Expands Horizons with Astaria Global Acquisition
- Investors Encouraged to Join Canopy Growth Class Action Suit
- Rosen Law Firm Initiates Investigation for Bitfarms Investors
- Agnico Eagle's 2025 Shareholder Meeting: Directors Elected
- Orbia's Exciting Offer: Tender for Senior Notes Unveiled
- Concord Medical Submits Annual Report for Fiscal Year 2024
- BankFirst Capital Corporation Posts Strong Q1 Performance
- Espire Dental Unifies Workforce at Engaging Conference Event
- Aliya Health Group Welcomes New Leaders to Enhance Care
- 17 Education & Technology Group Inc. Releases Annual Financial Report
- Kellanova Board Approves New $0.57 Dividend for Shareholders
- Exploring Christian Zionism: New Podcast Series Launches
- Graze Robotics and Invited Launch Pioneering Mowing Initiative
- Medtronic's OmniaSecure Lead Revolutionizes Cardiac Care Innovations
- Celebrate Planning with Plum Paper's Customer Appreciation Sale
- Innovative Grant Initiative to Foster Community Health Equity
- Investigating the HarborOne Bancorp and Eastern Bankshares Deal
- Celularity Faces Delisting Notice From Nasdaq Over Fees
- Paul Mueller Company Q1 Earnings Show Significant Growth
- Trillion Energy Takes Major Steps to Restructure Debt Efficiently
- Credicorp Ltd. Files Annual Report Showcasing Growth Insights
- Wheels Up's Commitment to Strategic Growth Amid NYSE Notice
- Fairfax Financial Holdings to Host Conference Call for Q1 Results
- AGF Investments Reveals New Final Distribution for ETF Holders
- Lug's Commitment to Sensory Accessibility with KultureCity Partnership
- Cadence Bank and Industry Bancshares Join Forces in Merger
- Zepp Health Corporation Announces Filing of 2024 Annual Report
- Innovative Neuro-Oncology Solutions with Dr. Neil A. Martin